Please read below for Labor Day holiday hours for the following departments in the Laboratory:
- Referrals Department (Spectrum Health Regional Laboratory, Grand Rapids)
- Outpatient Draw Sites (Outpatient Phlebotomy)
- Flow Cytometry Laboratory (Advanced Technology Laboratory, Grand Rapids)
Effective September 1, 2019, the test Drug of Abuse Screen, Pain Clinic, Urine will be discontinued.
Earlier this year, Spectrum Health Regional Laboratory – Toxicology announced two new drug screen panels, Urine Drug Screen with Confirmation (23 Targets) and Urine Drug Screen with Confirmation (32 Targets) as replacement tests. For more information regarding these new tests please reference this post.
Please join us in welcoming our new pathologists to Spectrum Health Regional Laboratory!
In an effort to streamline laboratory processes and provide expedited results, the test Herpes Simplex 1 / 2 IGG IGM was replaced with Herpes Simplex Panel on July 17, 2019. The new panel will still offer both Herpes IgM and Herpes IgG. The conversion to this panel will allow the lab to report Herpes IgG results faster.
The Spectrum Health Regional Laboratory Hematology Department has updated rejection criteria for the orderables, Cell Count w/ Differential, Body Fluid and Cell Count, Body Fluid. Spectrum Health Hematology will no longer perform cell counts on specimens which are not from a sterile body cavity (e.g. wound drainage, abscess, pus, etc.). Unacceptable specimens submitted to the Hematology Department for cell counts will not be performed and the test will be credited.
Effective June 17, 2019, Procollagen 1 intact N-terminal (P1NP) testing will change from a sendout reference radioimmunoassay test to Mayo Medical Laboratories to an in-house chemiluminescence assay performed by Spectrum Health Regional Laboratory.
Effective June 17, 2019, Anti-Müllerian Hormone (AMH) testing will change from a sendout reference test to Mayo Clinic Laboratories to an in-house test performed by Spectrum Health Regional Laboratory.
Due to low volume, Osteocalcin Blood Level will be discontinued. Recommended alternative test for bone formation evaluation is Procollagen I Intact N-Terminal, Serum (P1NP).
Spectrum Health Regional Laboratories will be upgrading the hematology instrumentation to the advanced technology of the Sysmex XN analyzers. This will occur on May 29, 2019, and will lead to a standardized approach to hematology results. Due to this upgrade, the following changes will occur:
Effective May 20, 2019, Spectrum Health Regional Laboratory Cytogenetics Department is pleased to announce the launch of a new microarray platform AffymetrixTM Cytoscan® HD. The Affymetrix Cytoscan HD is designed for the accurate and comprehensive analysis of chromosomal variants in the human genome.